Rankings
▼
Calendar
PHIO Q4 2019 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$16,000
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-507.38
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$31,000
Balance Sheet
Total Assets
$8M
Total Liabilities
$2M
Stockholders' Equity
$6M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$16,000
-$944,000
+98.3%
Operating Income
-$3M
-$2M
-53.9%
Net Income
-$3M
-$2M
-54.0%
← FY 2019
All Quarters
Q1 2020 →